A MSLN-targeted multifunctional nanoimmunoliposome for MRI and targeting therapy in pancreatic cancer

Pancreatic cancer is a highly lethal disease with a 5-year survival rate less than 5% due to the lack of an early diagnosis method and effective therapy. To provide a novel early diagnostic method and targeted therapy for pancreatic cancer, a multifunctional nanoimmunoliposome with high loading of u...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Li, Ke, Xingfa, He, Zhiying, Yang, Daoqiu, Gong, Hai, Zhang, Yingying, Jing, Xiaolong, Yao, Jianzhong, Chen, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3449755/
https://www.ncbi.nlm.nih.gov/pubmed/23028227
http://dx.doi.org/10.2147/IJN.S34801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3449755/
https://www.ncbi.nlm.nih.gov/pubmed/23028227
http://dx.doi.org/10.2147/IJN.S34801

Ejemplares similares